Kewaunee Scientific CORP /DE/ Form 4 insider transactions

NASDAQ
Kewaunee Scientific Corporation CEO, Thomas David Hull III, sold 1,000 shares of common stock on December 16, 2024.
NASDAQ
Kewaunee Scientific Corporation's President and CEO, Thomas David Hull III, has gifted 1,000 shares of company stock while retaining a substantial ownership position.
NASDAQ
CEO Thomas David Hull III exercised stock options and disposed of shares to cover exercise costs and tax obligations.
NASDAQ
Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, exercised stock options and disposed of shares to cover the exercise cost and tax obligations.
NASDAQ
CEO Thomas David Hull III reports the acquisition and disposal of Kewaunee Scientific Corp common stock and restricted stock units on June 30 and July 1, 2024.
NASDAQ
Donald T. Gardner III, CFO of Kewaunee Scientific Corp, reports the vesting and disposal of restricted stock units and common stock.
NASDAQ
Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, reports the vesting and disposal of restricted stock units and common stock transactions.
NASDAQ
Ryan S. Noble, VP-Sales & Marketing-Americas at Kewaunee Scientific Corp, reports the vesting of restricted stock units and subsequent disposal of shares to cover tax obligations.
NASDAQ
Mandar Ranade, VP-Information Technology at Kewaunee Scientific Corp, reports the exercise of restricted stock units and subsequent disposal of shares to cover tax obligations.
NASDAQ
Elizabeth D Phillips, VP of Human Resources at Kewaunee Scientific Corp, reports the vesting and subsequent disposal of restricted stock units, along with other stock transactions.
NASDAQ
Donald T. Gardner III, CFO of Kewaunee Scientific Corp, reports the acquisition of restricted stock units.
NASDAQ
CEO Thomas Hull III of Kewaunee Scientific Corp. reports the acquisition of restricted stock units.
NASDAQ
Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, acquired 4,142 restricted stock units on June 26, 2024, with vesting contingent upon continued employment and performance goals.
NASDAQ
Ryan S. Noble, VP-Sales & Marketing-Americas at Kewaunee Scientific Corp, acquired 4,007 restricted stock units on June 26, 2024, according to a Form 4 filing.
NASDAQ
Mandar Ranade, VP-Information Technology at Kewaunee Scientific Corp, received 4,017 restricted stock units on June 26, 2024, according to a Form 4 filing.
NASDAQ
Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, received 3,760 restricted stock units on June 26, 2024, with vesting contingent upon continued employment and performance goals.
NASDAQ
Director Margaret B. Pyle reported a gift of 450 shares of Kewaunee Scientific Corp common stock to a grandchild on May 17, 2024.
NASDAQ
Ryan S. Noble, VP-Sales & Marketing-Americas at Kewaunee Scientific Corp, sold a total of 750 shares of common stock in two transactions on March 26 and 27, 2024.
NASDAQ
Mandar Ranade, VP-Information Technology at Kewaunee Scientific Corp, sold 400 shares of common stock at a price of $33.1 on March 27, 2024.
NASDAQ
Elizabeth D Phillips, VP Human Resources at Kewaunee Scientific Corp, sold 3,277 shares of common stock on March 26, 2024.
NASDAQ
Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, sold 3,500 shares of common stock at a price of $31.35 on March 15, 2024.
NASDAQ
VP-Information Technology at Kewaunee Scientific Corp, Ranade Mandar, sold 3,000 shares of common stock on March 14, 2024, at an average price of $30.85.